Cargando…

Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System

Anthocyanins have been shown to be effective in chronic diseases because of their antioxidant and anti-inflammatory effects together with changes in the gut microbiota and modulation of neuropeptides such as insulin-like growth factor-1. This review will examine whether these mechanisms may be effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Panchal, Sunil K., Brown, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822395/
https://www.ncbi.nlm.nih.gov/pubmed/36615279
http://dx.doi.org/10.3390/molecules28010080
_version_ 1784865935573647360
author Panchal, Sunil K.
Brown, Lindsay
author_facet Panchal, Sunil K.
Brown, Lindsay
author_sort Panchal, Sunil K.
collection PubMed
description Anthocyanins have been shown to be effective in chronic diseases because of their antioxidant and anti-inflammatory effects together with changes in the gut microbiota and modulation of neuropeptides such as insulin-like growth factor-1. This review will examine whether these mechanisms may be effective to moderate the symptoms of disorders of the central nervous system in humans, including schizophrenia, Parkinson’s disease, Alzheimer’s disease, autism spectrum disorder, depression, anxiety, attention-deficit hyperactivity disorder and epilepsy. Thus, anthocyanins from fruits and berries should be considered as complementary interventions to improve these chronic disorders.
format Online
Article
Text
id pubmed-9822395
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98223952023-01-07 Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System Panchal, Sunil K. Brown, Lindsay Molecules Review Anthocyanins have been shown to be effective in chronic diseases because of their antioxidant and anti-inflammatory effects together with changes in the gut microbiota and modulation of neuropeptides such as insulin-like growth factor-1. This review will examine whether these mechanisms may be effective to moderate the symptoms of disorders of the central nervous system in humans, including schizophrenia, Parkinson’s disease, Alzheimer’s disease, autism spectrum disorder, depression, anxiety, attention-deficit hyperactivity disorder and epilepsy. Thus, anthocyanins from fruits and berries should be considered as complementary interventions to improve these chronic disorders. MDPI 2022-12-22 /pmc/articles/PMC9822395/ /pubmed/36615279 http://dx.doi.org/10.3390/molecules28010080 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Panchal, Sunil K.
Brown, Lindsay
Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
title Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
title_full Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
title_fullStr Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
title_full_unstemmed Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
title_short Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System
title_sort potential benefits of anthocyanins in chronic disorders of the central nervous system
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822395/
https://www.ncbi.nlm.nih.gov/pubmed/36615279
http://dx.doi.org/10.3390/molecules28010080
work_keys_str_mv AT panchalsunilk potentialbenefitsofanthocyaninsinchronicdisordersofthecentralnervoussystem
AT brownlindsay potentialbenefitsofanthocyaninsinchronicdisordersofthecentralnervoussystem